Morning Briefing
Summaries of health policy coverage from major news organizations
Pharmaceutical Companies' Profit Protection Hurts Global AIDS Fight
In her latest piece on the New York Times' "Opinionator" blog, author and journalist Tina Rosenberg argues that the terms of Gilead's recent agreement with the Medicines Patent Pool is "confirmation of a dangerous new trend: middle-income countries as a target market for drug makers." "The new strategy is to treat people in Egypt, Paraguay, Turkmenistan or China
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
